205 related articles for article (PubMed ID: 31858647)
1. Kinesin family member 2A high expression correlates with advanced tumor stages and worse prognosis in non-small cell lung cancer patients.
Wang G; Wang Z; Yu H
J Clin Lab Anal; 2020 Apr; 34(4):e23135. PubMed ID: 31858647
[TBL] [Abstract][Full Text] [Related]
2. Kinesin family member 2A links with advanced tumor stage, reduced chemosensitivity and worse prognosis in gastric cancer.
Bai F; He Z; Zhou H; Gan W
J Clin Lab Anal; 2022 May; 36(5):e24313. PubMed ID: 35313389
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
Yan B; Zhang W; Mao XW; Jiang LY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA SMARCA5 may serve as a tumor suppressor in non-small cell lung cancer.
Tong S
J Clin Lab Anal; 2020 May; 34(5):e23195. PubMed ID: 31944395
[TBL] [Abstract][Full Text] [Related]
5. Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer.
Xu L; Zhang X; Wang Z; Zhao X; Zhao L; Hu Y
Am J Transl Res; 2021; 13(4):2060-2076. PubMed ID: 34017375
[TBL] [Abstract][Full Text] [Related]
6. High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma.
Xie T; Li X; Ye F; Lu C; Huang H; Wang F; Cao X; Zhong C
Biochem Biophys Res Commun; 2018 Feb; 497(1):65-72. PubMed ID: 29427669
[TBL] [Abstract][Full Text] [Related]
7. KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer.
Wang J; Ma S; Ma R; Qu X; Liu W; Lv C; Zhao S; Gong Y
BMC Cancer; 2014 Jun; 14():461. PubMed ID: 24950762
[TBL] [Abstract][Full Text] [Related]
8. EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Tian Y; Zhao K; Yuan L; Li J; Feng S; Feng Y; Fang Z; Li H; Deng R
Cancer Biomark; 2018; 23(2):291-300. PubMed ID: 30198870
[TBL] [Abstract][Full Text] [Related]
9. Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non-small cell lung cancer.
Li L; Xu B; Zhang H; Wu J; Song Q; Yu J
J Clin Lab Anal; 2020 Jan; 34(1):e23031. PubMed ID: 31713908
[TBL] [Abstract][Full Text] [Related]
10. The molecular mechanism of kinesin family member 2A (KIF2A) underlying non-small cell lung cancer: the effect of its knockdown on malignant behaviors, stemness, chemosensitivity, and potential regulated signaling pathways.
Chen J; Wen J; Liu D; Xu X; Fan M; Zhang Z
Am J Transl Res; 2022; 14(1):68-85. PubMed ID: 35173830
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
Zhang M; Wen F; Zhao K
J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer.
Wang D; Zhu H; Ye Q; Wang C; Xu Y
Medicine (Baltimore); 2016 Feb; 95(8):e2803. PubMed ID: 26937910
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of kinesin family member 2A as a facilitating biomarker of disease surveillance and prognostication in cervical cancer patients.
Lei G; Xin X; Hu X
Ir J Med Sci; 2022 Apr; 191(2):665-670. PubMed ID: 33797694
[TBL] [Abstract][Full Text] [Related]
14. KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer.
Fan X; Wang X; Zhu H; Wang W; Zhang S; Wang Z
Tumour Biol; 2015 Nov; 36(11):8895-902. PubMed ID: 26070867
[TBL] [Abstract][Full Text] [Related]
15. Kinesin Family Member 2A Serves as a Potential Biomarker Reflecting More Frequent Lymph Node Metastasis and Tumor Recurrence Risk in Basal-Like Breast Cancer Patients.
Yang H; Liu Y
Front Surg; 2022; 9():889294. PubMed ID: 35784940
[TBL] [Abstract][Full Text] [Related]
16. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
Chen H; Yan S; Dong L; Li X
J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
[TBL] [Abstract][Full Text] [Related]
17. Aberrant kinesin family member 2A signifies tumor size and invasion, and may help predict prognosis of patients with papillary thyroid carcinoma.
Zhang X; Wu M; Peng G; Li W; Guo Z; Li H; Jiang M
Oncol Lett; 2022 Aug; 24(2):256. PubMed ID: 35765280
[TBL] [Abstract][Full Text] [Related]
18. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
19. IGF2BP1 facilitates non-small cell lung cancer progression by regulating the KIF2A-mediated Wnt/β-catenin pathway.
Sun M; Wang L; Ge L; Xu D; Zhang R
Funct Integr Genomics; 2023 Dec; 24(1):4. PubMed ID: 38102458
[TBL] [Abstract][Full Text] [Related]
20. C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer.
Wei L; Liu Y; Ma Y; Ding C; Zhang H; Lu Z; Gu Z; Zhu C
Cell Cycle; 2019 Dec; 18(24):3456-3471. PubMed ID: 31731888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
